Segall Bryant & Hamill’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-36,890
Closed -$2.78M 606
2026
Q1
$2.78M Sell
36,890
-1,119
-3% -$82.3K 0.04% 379
2025
Q4
$2.58M Buy
38,009
+5,235
+16% +$327K 0.03% 398
2025
Q3
$1.87M Sell
32,774
-127
-0.4% -$7.53K 0.02% 444
2025
Q2
$1.82M Buy
+32,901
New +$1.54M 0.03% 448

Other funds holding DBD

Segall Bryant & Hamill's DBD Position: Q2 2026 in Review

Segall Bryant & Hamill sold out of Diebold Nixdorf (DBD) in Q2 2026, closing a stake of 36,890 shares — an estimated $2.78M sold.

Segall Bryant & Hamill first reported a position in DBD in Q2 2025 and held it in 4 quarters. The position peaked at $2.78M in Q1 2026. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • Segall Bryant & Hamill reported no remaining Diebold Nixdorf position as of Q2 2026 after selling out during the quarter.
  • Segall Bryant & Hamill sold 36,890 Diebold Nixdorf shares in Q2 2026, an estimated $2.78M.
  • Segall Bryant & Hamill first reported a position in Diebold Nixdorf in Q2 2025 and held it in 4 quarters.
  • Segall Bryant & Hamill's Diebold Nixdorf position peaked at $2.78M in Q1 2026.
  • 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.